Baby Eva with mother Susan Walker-Dempster and father David Dempster at the Glasgow Centre for Reproductive Medicine (GCRM) in Scotland. Photo: Danny Lawson, PA WireBaby Eva with mother Susan Walker-Dempster and father David Dempster at the Glasgow Centre for Reproductive Medicine (GCRM) in Scotland. Photo: Danny Lawson, PA Wire

The Glasgow Centre for Reproductive Medicine (GCRM), one of the UK’s most innovative IVF clinics, announced the birth of the first baby to be born in Scotland using a groundbreaking new approach to IVF, the Early Embryo Viability Assessment (Eeva) test, that improves embryo selection.

Scotland is welcoming Baby Eva today, the world’s first baby to be born and named by her parents after the new Eeva test. Eva was born on June 11 following Susan Walker-Dempster and David Dempster’s hardship of trying to build a family together.

Susan and David chose to have the Eeva test at the GCRM to increase their chances of IVF success. The new mother, Susan said “we wanted every chance to be successful, so we chose Eeva”.

The Eeva test uses unique predictive software in combination with a time-lapse analysis technique to automatically analyse embryo development against scientifically and clinically validated cell-division parameters. The test aids embryologists in selecting the most viable embryos for transfer, potentially increasing the chances of a successful IVF cycle.

Richard Fleming at GCRM said: “We are very proud to be among the first clinics in the world to announce this news as it demonstrates how successful this new technology can be in enabling couples to have a higher chance of conceiving a baby with IVF. GCRM has always strived to be one of the leading IVF centres in Europe, offering couples the latest innovations with the best possible outcomes. The Eeva test is the practical end point of good quality research and is the start of a new chapter in the evolution of IVF.”

“We are delighted to hear the news of this successful birth and wish the family the very best,” said Lissa Goldenstein, president and CEO of Auxogyn Inc. “The Eeva test has been developed to give IVF clinicians objective information about the embryo and provide insight into its growth potential. With more couples choosing to use Eeva, we are looking forward to many more births like Baby Eva today.”

 

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.